Featured Research

from universities, journals, and other organizations

Fungus-fighting drug may make mild flu meaner

Date:
November 21, 2013
Source:
Cell Press
Summary:
Mice given a drug commonly used in patients to fight systemic fungal infections more often succumb to what would otherwise be a mild case of the flu. The evidence shows that the drug called Amphotericin B, which has an estimated $330 million in sales around the world each year, can render a protein important for antiviral defense ineffective in both cells and mice.

Mice given a drug commonly used in patients to fight systemic fungal infections more often succumb to what would otherwise be a mild case of the flu. The evidence reported in the Cell Press journal Cell Reports on November 21st shows that the drug called Amphotericin B, which has an estimated $330 million in sales around the world each year, can render a protein important for antiviral defense ineffective in both cells and mice.

The findings suggest that patients receiving the antifungal therapy may be functionally immunocompromised and more vulnerable to influenza and other viral infections, the researchers said.

"Many critically ill cancer and bone marrow transplant patients are treated with Amphotericin B-based therapies each year," said Abraham Brass of the University of Massachusetts Medical School (UMMS). "Given these results in cells and mice, it may be worthwhile to consider that patients receiving, or who may receive, Amphotericin B-based therapies be appropriately vaccinated against influenza virus. Also, clinical consideration may be given to close monitoring of patients receiving Amphotericin B-based therapies for any symptoms suggestive of flu so that they might be considered for the early administration of an antiflu therapy."

The researchers showed that Amphotericin-B prevents the antiviral protein in cells known as IFITM3 from fending off influenza A virus.

"When we treated lung cancer cells with the antifungal drug, we saw the antiviral protection from IFITM3 pretty much disappear," explained Christopher Chin, co-first author, also from UMMS.

When researchers in Paul Kellam's group at the Wellcome Trust Sanger Institute exposed mice treated with Amphotericin-B to influenza A virus, the animals became very ill and lost more than 25 percent of their body weight. Those symptoms looked very similar to those in animals completely lacking the protective IFITM3 protein. Mice that had not been treated with Amphotericin-B experienced only a moderate illness and recovered fully, as expected. In effect, treatment with Amphotericin-B converted a mild illness for the mice into a life-threatening one.

"Sometimes a very useful drug can have unforeseen effects, and the more we can learn about such things, the better care we can provide," Brass said.

The new study should prompt further clinical research. For instance, he added, studies could be designed to monitor both the number and the severity of flu infections in patients receiving Amphotericin B-based therapies.


Story Source:

The above story is based on materials provided by Cell Press. Note: Materials may be edited for content and length.


Journal Reference:

  1. Lin et al. Amphotericin B Increases Influenza A Virus Infection by Preventing IFITM3-mediated Restriction. Cell Reports, November 2013

Cite This Page:

Cell Press. "Fungus-fighting drug may make mild flu meaner." ScienceDaily. ScienceDaily, 21 November 2013. <www.sciencedaily.com/releases/2013/11/131121125857.htm>.
Cell Press. (2013, November 21). Fungus-fighting drug may make mild flu meaner. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2013/11/131121125857.htm
Cell Press. "Fungus-fighting drug may make mild flu meaner." ScienceDaily. www.sciencedaily.com/releases/2013/11/131121125857.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Cases Keep Coming for Monrovia's Island Hospital

Ebola Cases Keep Coming for Monrovia's Island Hospital

AFP (Oct. 1, 2014) A look inside Monrovia's Island Hospital, a key treatment centre in the fight against Ebola in Liberia's capital city. Duration: 00:34 Video provided by AFP
Powered by NewsLook.com
Ebola Puts Stress on Liberian Health Workers

Ebola Puts Stress on Liberian Health Workers

AP (Oct. 1, 2014) The Ebola outbreak is putting stress on first responders in Liberia. Ambulance drivers say they are struggling with chronic shortages of safety equipment and patients who don't want to go to the hospital. (Oct. 1) Video provided by AP
Powered by NewsLook.com
Doctors Reassure Public Ebola Patient Won't Cause Outbreak

Doctors Reassure Public Ebola Patient Won't Cause Outbreak

Newsy (Sep. 30, 2014) After the announcement that the first U.S. patient had been diagnosed with Ebola, doctors were quick to say a U.S. outbreak is highly unlikely. Video provided by Newsy
Powered by NewsLook.com
TX Hospital Confirms Patient Admitted With Ebola

TX Hospital Confirms Patient Admitted With Ebola

AP (Sep. 30, 2014) Medical officials from Texas Health Presbyterian Hospital confirm they are treating a patient with the Ebola virus, the first case found in the US. (Sept. 30 Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins